Cardiovascular outcomes with ertugliflozin in type 2 diabetes

for the VERTIS CV Investigators

Research output: Contribution to journalArticlepeer-review

949 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiovascular outcomes with ertugliflozin in type 2 diabetes'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science